This book explores the legal and ethical dilemmas that arise from the procurement, storage and use of stem cells derived from the umbilical cord of new-born infants. Karen Devine traces the emergence of umbilical cord blood (UCB) as a biological resource of potential therapeutic value, and introduces the medical researchers, practitioners and patients that fought to prove its worth.